Factors associated with time until metastatic spread in patients with primary uveal melanoma: A retrospective analysis
- PMID: 40828748
- PMCID: PMC12364332
- DOI: 10.1371/journal.pone.0328360
Factors associated with time until metastatic spread in patients with primary uveal melanoma: A retrospective analysis
Abstract
Purpose: To characterize patients with choroidal or ciliary body (CB) melanoma in order to identify factors associated with time until metastasis and further perform a detailed characterization of the factors identified.
Methods: A mixed model approach was used to identify parameters and patient characteristics associated with time until metastatic event. Consequently, the identified parameters were characterized.
Results: In 383 patients with primary choroidal and CB melanoma, tumor thickness and patient age at diagnosis are associated with time until metastatic event. Mean patient age was 61 ± 13 years, mean choroidal and CB melanoma thickness was 5.1 ± 1.9 mm. Other factors investigated comprising sex, primary tumor width, length, volume, shape, and type of therapy are not associated with time until metastatic event in this patient collective.
Conclusion: In conclusion, this study expands the current knowledge on factors associated with metastasis due to primary choroidal or CB melanoma. So far primary choroidal or CB melanoma thickness has been shown to be a risk indicator for metastatic events. Now, we could show that primary choroidal or CB melanoma thickness is also correlated with time until metastatic event. The association can be expressed as: the thicker the primary tumor, the earlier the potential metastatic event. Age may be considered an indirect effect in the model calculated.
Copyright: © 2025 Told et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Systemic treatments for metastatic cutaneous melanoma.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2. Cochrane Database Syst Rev. 2018. PMID: 29405038 Free PMC article.
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21. Clin Orthop Relat Res. 2025. PMID: 38905450
References
LinkOut - more resources
Full Text Sources